Synapse - Works

Results (116513)

Association of metabolic tumor volume (MTV) and clinical outcomes in second-line (2L) relapsed/refractory (R/R) large B-cell lymphoma (LBCL) following axicabtagene ciloleucel (axi-cel) versus standard-of-care (soc) therapy in ZUMA-7

Meeting Abstract

Locke, F. L.; Oluwole, O. O.; Kuruvilla, J.; Thieblemont, C.; Morschhauser, F.; Salles, G.; Rowe, S. P.; Vardhanabhuti, S.; Filosto, S.; To, C.; more...
Blood (2022)

Fulltext@MSK | Save

SARS-CoV-2 vaccinations do not lead to progression of monoclonal gammopathy of undetermined significance: Results from the population-based iStopMM screening study

Meeting Abstract

Palmason, R.; Eythorsson, E.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Ekberg, S.; Crowther, M.; Reed, E. R.; Oskarsson, J. Þ.; Sigurdardottir, G. A.; Aspelund, T.; more...
Blood (2022)

Fulltext@MSK | Save

Predictors and outcomes of immune effector cell associated neurotoxicity syndrome in patients receiving chimeric antigen receptor T-cell therapy for aggressive B-cell non-Hodgkin lymphoma

Meeting Abstract

Patel, V.; Bhaskar, S.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Shouval, R.; McGuirk, J. P.; Maziarz, R. T.; Chen, A.; Bachanova, V.; more...
Blood (2022)

Fulltext@MSK | Save

Safety and efficacy of the PI3Kδ inhibitor zandelisib in combination with the BTK inhibitor zanubrutinib in patients with relapsed/refractory (R/R) follicular lymphoma (FL) or mantle cell lymphoma (MCL)

Meeting Abstract

Soumerai, J. D.; Diefenbach, C. S.; Samaniego, F.; Kumar, A.; Tsai, M. L.; Asch, A. S.; Jagadeesh, D.; Kenkre, V. P.; Lossos, I. S.; Salman, H.; more...
Blood (2022)

Fulltext@MSK | Save

Subcutaneous epcoritamab in patients with Richter's syndrome: Early results from phase 1b/2 trial (EPCORE CLL-1)

Meeting Abstract

Kater, A. P.; Ye, J. C.; Sandoval-Sus, J.; Bellido, M.; Christensen, J. H.; Mato, A. R.; Janssens, A.; Oki, T.; Hoehn, D.; Rios, M.; more...
Blood (2022)

Fulltext@MSK | Save

Prevalence of MGUS is high in the iStopMM study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do

Meeting Abstract

Love, T. J.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Aspelund, T.; Reed, E. R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; Sigurdardottir, M.; Thorsteinsdottir, I.; more...
Blood (2022)

Fulltext@MSK | Save

The high mobility group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation

Meeting Abstract

Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R. K.; Koche, R.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
Blood (2022)

Fulltext@MSK | Save

The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study

Meeting Abstract

Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
Blood (2022)

Fulltext@MSK | Save

Pediatric-specific patterns of clonal evolution arising from acquired aplastic anemia

Meeting Abstract

Oved, J. H.; Shah, Y.; Li, Y.; Monos, D. S.; Babushok, D. V.; Luo, M.; Li, M. M.; Olson, T. S.
Blood (2022)

Fulltext@MSK | Save

Molecular features associated with response to combination therapy with enasidenib (ENA) plus azacitidine (AZA) in newly diagnosed IDH2-mutated acute myeloid leukemia (AML)

Meeting Abstract

Risueño, A.; See, W. L.; DiNardo, C. D.; Döhner, H.; Stein, E.; Fathi, A. T.; Vyas, P.; Quek, L.; Prebet, T.; Gandhi, A. K.; more...
Blood (2022)

Fulltext@MSK | Save